Alberto Verlicchi - Search Results

Year	Number of Results
2012	1
2013	1
2014	1
2015	3
2016	2
2017	3
2019	4
2020	2
2021	1
2023	3
2024	1

1

Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.

Gentili N, Balzi W, Foca F, Danesi V, Altini M, Delmonte A, Bronte G, Crinò L, De Luigi N, Mariotti M, Verlicchi A, Burgio MA, Roncadori A, Burke T, Massa I. Gentili N, et al. Among authors: verlicchi a. Cancers (Basel). 2024 Jan 30;16(3):592. doi: 10.3390/cancers16030592. Cancers (Basel). 2024. PMID: 38339345 Free PMC article.

2

Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer.

Andrikou K, Rossi T, Verlicchi A, Priano I, Cravero P, Burgio MA, Crinò L, Bandini S, Ulivi P, Delmonte A. Andrikou K, et al. Among authors: verlicchi a. Int J Mol Sci. 2023 Nov 8;24(22):16085. doi: 10.3390/ijms242216085. Int J Mol Sci. 2023. PMID: 38003273 Free PMC article. Review.

3

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer.

Verlicchi A, Canale M, Chiadini E, Cravero P, Urbini M, Andrikou K, Pasini L, Flospergher M, Burgio MA, Crinò L, Ulivi P, Delmonte A. Verlicchi A, et al. Life (Basel). 2023 Sep 15;13(9):1915. doi: 10.3390/life13091915. Life (Basel). 2023. PMID: 37763318 Free PMC article. Review.

4

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.

Karachaliou N, Codony-Servat J, Teixidó C, Pilotto S, Drozdowskyj A, Codony-Servat C, Giménez-Capitán A, Molina-Vila MA, Bertrán-Alamillo J, Gervais R, Massuti B, Morán T, Majem M, Felip E, Carcereny E, García-Campelo R, Viteri S, González-Cao M, Morales-Espinosa D, Verlicchi A, Crisetti E, Chaib I, Santarpia M, Luis Ramírez J, Bosch-Barrera J, Felipe Cardona A, de Marinis F, López-Vivanco G, Miguel Sánchez J, Vergnenegre A, Sánchez Hernández JJ, Sperduti I, Bria E, Rosell R. Karachaliou N, et al. Among authors: verlicchi a. Sci Rep. 2023 Mar 3;13(1):3620. doi: 10.1038/s41598-023-30374-9. Sci Rep. 2023. PMID: 36869103 Free PMC article. No abstract available.

5

Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors.

Bronte G, Verlicchi A, De Matteis S, Rossi A, Affatato A, Sullo FG, Gianni C, Canale M, Burgio MA, Delmonte A, Milella M, Crinò L. Bronte G, et al. Among authors: verlicchi a. Front Immunol. 2021 May 27;12:672219. doi: 10.3389/fimmu.2021.672219. eCollection 2021. Front Immunol. 2021. PMID: 34122429 Free PMC article.

6

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs.

Canale M, Petracci E, Delmonte A, Bronte G, Chiadini E, Ludovini V, Dubini A, Papi M, Baglivo S, De Luigi N, Verlicchi A, Chiari R, Landi L, Metro G, Burgio MA, Crinò L, Ulivi P. Canale M, et al. Among authors: verlicchi a. J Clin Med. 2020 Apr 7;9(4):1047. doi: 10.3390/jcm9041047. J Clin Med. 2020. PMID: 32272775 Free PMC article.

7

Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement.

Bronte G, Delmonte A, Burgio MA, Verlicchi A, Puccetti M, Bravaccini S, Cravero P, Tumedei MM, Diano D, Rossi G, Ulivi P, Martinelli G, Crinò L. Bronte G, et al. Among authors: verlicchi a. Lung Cancer. 2020 Apr;142:47-50. doi: 10.1016/j.lungcan.2020.02.006. Epub 2020 Feb 14. Lung Cancer. 2020. PMID: 32088605

8

New generation anaplastic lymphoma kinase inhibitors.

Delmonte A, Burgio MA, Verlicchi A, Bronte G, Cravero P, Ulivi P, Martinelli G, Crinò L. Delmonte A, et al. Among authors: verlicchi a. Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S280-S289. doi: 10.21037/tlcr.2019.09.14. Transl Lung Cancer Res. 2019. PMID: 31857951 Free PMC article. Review.

9

Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.

Ito M, Codony-Servat C, Codony-Servat J, Lligé D, Chaib I, Sun X, Miao J, Sun R, Cai X, Verlicchi A, Okada M, Molina-Vila MA, Karachaliou N, Cao P, Rosell R. Ito M, et al. Among authors: verlicchi a. Cell Commun Signal. 2019 Oct 28;17(1):137. doi: 10.1186/s12964-019-0446-z. Cell Commun Signal. 2019. PMID: 31660987 Free PMC article.

10

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer.

De Matteis S, Canale M, Verlicchi A, Bronte G, Delmonte A, Crinò L, Martinelli G, Ulivi P. De Matteis S, et al. Among authors: verlicchi a. J Oncol. 2019 Aug 19;2019:7475364. doi: 10.1155/2019/7475364. eCollection 2019. J Oncol. 2019. PMID: 31531020 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year